학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

Antitumor activity of osimertinib, an irreversible mutant-selective EGFR tyrosine kinase inhibitor, in NSCLC harboring EGFR exon 20 insertions

Document Type

Article

Author

Floc'h, N.; Martin, M.J.; Staniszewska, A.D.; Menard, L.; Ward, R.A.; McKerrecher, D.; Cross, D.A.E.; Riess, J.W.; Vang, D.P.; Burich, R.A.; Gandara, D.R.; Mack, P.C.; Orme, J.P.; Cuomo, M.E.; O'Neill, D.J.; Cheng, M.; Keck, J.G.; Finlay, R.M.V.

Source

In: Molecular Cancer Therapeutics. (Molecular Cancer Therapeutics, May 2018, 17(5):885-896)

Subject

Language

English

ISSN

15388514
15357163

Online Access

Full Text (ECC - 개별구독 전자저널) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일